Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Thumbnail

What PET imaging can tell cardiologists about post-heart transplant survival

New research published in the Journal of Nuclear Medicine suggests PET myocardial perfusion imaging can be used to quantify myocardial blood flow and myocardial flow reserve, which have been proven as accurate indicators of adverse outcomes after heart transplants.

Thumbnail

PET imaging years after heart transplant surgery can save lives

Cardiac allograft vasculopathy is one of the most serious conditions that transplant patients face after surgery, but now clinicians have gained an upper hand in the fight.

Thumbnail

‘Potentially everything we’ve hoped for’: Pulsed field ablation used for 1st time in U.S.

Pulsed field ablation technology has been used to treat atrial fibrillation for the first time in the U.S.

Thumbnail

Orsiro stent continues to outperform Xience at 3 years

Three-year data from the BIOFLOW-V trial, presented Feb. 23 at the 2020 CRT Congress in National Harbor, Md., reinforce the status of Biotronik’s Orsiro drug-eluting stent as superior to the popular Xience stent.

Thumbnail

EKGs may soon screen for cardiomyopathy, thanks to AI

An AI-based approach to diagnostics could see electrocardiograms repurposed to screen for hypertrophic cardiomyopathy in the not-so-distant future.

Thumbnail

Portable MRIs bring imaging to stroke patients’ bedsides

Research presented at the American Stroke Association’s International Stroke Conference in Los Angeles this February suggests a portable, low-field MRI system may soon improve access to care for patients who have trouble making it to a high-tech facility.

AI predicts MI, stroke, death from blood flow

In an industry first, an AI algorithm has been used to instantly and accurately assess patients’ blood flow, acting as a risk prediction tool for major adverse CV events.

Thumbnail

FDA greenlights AI-guided CV ultrasound acquisition system

Medical AI company Caption Health announced Feb. 7 that the FDA had authorized marketing for its Caption Guidance software.